Table of Contents Author Guidelines Submit a Manuscript
Journal of Spectroscopy
Volume 2014, Article ID 285806, 5 pages
http://dx.doi.org/10.1155/2014/285806
Research Article

Assessment of the Inhibitory Effect of Rifampicin on Amyloid Formation of Hen Egg White Lysozyme: Thioflavin T Fluorescence Assay versus FTIR Difference Spectroscopy

Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of Ministry of Education, College of Chemistry and Environmental Science, Hebei University, Baoding 071002, China

Received 6 September 2013; Revised 31 October 2013; Accepted 14 December 2013; Published 6 January 2014

Academic Editor: Yizhuang Xu

Copyright © 2014 Gang Ma et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Sawaya, S. Sambashivan, R. Nelson et al., “Atomic structures of amyloid cross-β spines reveal varied steric zippers,” Nature, vol. 447, no. 7143, pp. 453–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. F. Chiti and C. M. Dobson, “Protein misfolding, functional amyloid, and human disease,” Annual Review of Biochemistry, vol. 75, pp. 333–366, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. P. T. Lansbury and H. A. Lashuel, “A century-old debate on protein aggregation and neurodegeneration enters the clinic,” Nature, vol. 443, no. 7113, pp. 774–779, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. J. D. Harper and P. T. Lansbury Jr., “Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins,” Annual Review of Biochemistry, vol. 66, pp. 385–407, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. C. G. Glabe, “Structural classification of toxic amyloid oligomers,” The Journal of Biological Chemistry, vol. 283, no. 44, pp. 29639–29643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Tomiyama, S. Asano, Y. Suwa et al., “Rifampicin prevents the aggregation and neurotoxicity of amyloid β protein in vitro,” Biochemical and Biophysical Research Communications, vol. 204, no. 1, pp. 76–83, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Li, M. Zhu, S. Rajamani, V. N. Uversky, and A. L. Fink, “Rifampicin inhibits α-synuclein fibrillation and disaggregates fibrils,” Chemistry and Biology, vol. 11, no. 11, pp. 1513–1521, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. J. Meier, R. Kayed, C.-Y. Lin et al., “Inhibition of human IAPP fibril formation does not prevent β-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP,” American Journal of Physiology: Endocrinology and Metabolism, vol. 291, no. 6, pp. E1317–E1324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. V. H. Lieu, J. W. Wu, S. S.-S. Wang, and C.-H. Wu, “Inhibition of amyloid fibrillization of hen egg-white lysozymes by rifampicin and p-benzoquinone,” Biotechnology Progress, vol. 23, no. 3, pp. 698–706, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Meng, P. Marek, K. J. Potter, C. B. Verchere, and D. P. Raleigh, “Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril thioflavin-T interactions: implications for mechanistic studies of β-cell death,” Biochemistry, vol. 47, no. 22, pp. 6016–6024, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. P. Kumar and D. Chatterji, “Resonance energy transfer study on the proximity relationship between GTP binding site and the rifampicin binding site of Escherichia coli RNA polymerase,” Biochemistry, vol. 29, no. 2, pp. 317–322, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Zou, Y. Li, W. Hao, X. Hu, and G. Ma, “Parallel β-sheet fibril and antiparallel β-sheet oligomer: new insights into amyloid formation of hen egg white lysozyme under heat and acidic condition from ftir spectroscopy,” The Journal of Physical Chemistry B, vol. 117, pp. 4003–4013, 2013. View at Publisher · View at Google Scholar
  13. H. LeVine III, “Quantification of β-sheet amyloid fibril structures with thioflavin T,” Methods in Enzymology, vol. 309, pp. 274–284, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. L. P. Jameson, N. W. Smith, and S. V. Dzyuba, “Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly,” ACS Chemical Neuroscience, vol. 3, pp. 807–819, 2012. View at Google Scholar
  15. R. Mishra, K. Sörgjerd, S. Nyström, A. Nordigården, Y.-C. Yu, and P. Hammarström, “Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion,” Journal of Molecular Biology, vol. 366, no. 3, pp. 1029–1044, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. S. A. Hudson, H. Ecroyd, T. W. Kee, and J. A. Carver, “The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds,” FEBS Journal, vol. 276, no. 20, pp. 5960–5972, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Barth and C. Zscherp, “What vibrations tell us about proteins,” Quarterly Reviews of Biophysics, vol. 35, no. 4, pp. 369–430, 2002. View at Publisher · View at Google Scholar · View at Scopus